Partnerships

Milagen has had many research and commercial partners over the years to advance our product line and introduce them to the market. Scroll down to learn more.

We are currently looking for like-minded investors and commercial partners to co-develop and commercialize our cancer tests. Please contact us below to start the discussion.

Select Partnerships

Milagen entered into partnerships with researchers from leading academic institutions and medical centers in order to advance the development of immunodiagnostic assays for early detection, prognosis and therapy management. These collaborations provided invaluable clinical expertise, unbiased feedback, and the chance for third-party validation of its products.

Early Detection Research Network (EDRN)

April 4, 2003

Establishment of a Confidentiality Agreement with the members of The Great Lakes-New England Clinical & Epidemiological Center of the Early Detection Research Network (EDRN), and the NCI.

University of California San Francisco (UCSF)

March 25, 2003

Further expansion of research collaboration with University of California San Francisco.

National Institutes of Health (NIH)

March 13, 2003

Milagen to initiate collaboration with the NIH Animal Models of Human Cancer Consortium.

Eastern Virginia Medical School

February 4, 2003

Research Collaboration with Eastern Virginia Medical School.

New York School of Medicine

January 1, 2003

Initiation of collaboration with New York School of Medicine.

Cancer Therapy and Research Center, San Antonio, TX

November 11, 2002

Establishment of Confidentiality Agreement with the Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, TX.

University of California San Francisco

November 7, 2002

Further research collaboration with University of California San Francisco.

Universitad Autonoma de Mexico (UNAM) and the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico

August 9, 2002

Establishment of research collaboration with the Universitad Autonoma de Mexico (UNAM) and the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, on metabolic diseases.

University of California, San Francisco

May 29, 2002

Expansion of collaborative effort with University of California San Francisco on other cancers.

Academia Sinica

May 20, 2002

Research collaboration with Academia Sinica, Taiwan.

Japanese Foundation for Cancer Research, Tokyo

April 9, 2002

Milagen to initiate research collaboration with Japanese Foundation for Cancer Research, Tokyo.

University of California, San Francisco

January 8, 2002

Milagen to pursue research collaboration with University of California San Francisco.